Unlabelled: To examine the impact before and after adoption of a procalcitonin-based protocol to guide sepsis management has on antibiotic use, care costs, and outcomes of critically ill patients.
Design: Before-after study.
Setting: ICU of an academic tertiary care center.
Patients: Adults over 18 years old admitted to the ICU from January 1, 2017, to January 31, 2020.
Interventions: In this before-after study, we compared the use of medications, outcomes, and overall cost before and after the introduction of a procalcitonin-based protocol for evaluation and treatment of sepsis.
Measurements And Main Results: The final study cohort consisted of 1,793 patients admitted to the ICU, 776 patients pre-procalcitonin and 1,017 patients in the post-procalcitonin period. Patients were not different in the pre-procalcitonin adoption period compared with post-procalcitonin adoption with regard to gender, age (62.0 vs 62.6), race, or comorbidities. Patients admitted during the post-procalcitonin adoption period were less likely to receive the examined broad-spectrum antibiotics (odds ratio, -0.58; CI, -0.99 to -0.17; < 0.01) than patients during the pre-procalcitonin adoption period. The odds of inhospital death did not differ after procalcitonin adoption when compared with before (0.87; CI, 0.70-1.09; = 0.234). Total charges for each admission were significantly less in the post-procalcitonin adoption period $3,834.99 compared with pre-procalcitonin adoption $4,429.47 ( < 0.05). Patients post-procalcitonin adoption incurred $1,127.18 per patient less in total charges (-1,127.18; CI, -2,014.74 to -239.62; = 0.013) after controlling for relevant factors.
Conclusions: In critically ill patients in a large U.S. tertiary care hospital, the adoption of a procalcitonin-based protocol for evaluation and treatment of sepsis may be associated with decreased antibiotic use and significant cost savings, with no change in mortality.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580196 | PMC |
| http://dx.doi.org/10.1097/CCE.0000000000000571 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Compliance with a Procalcitonin-Based Protocol in Patients with Ventilation-Associated Pneumonia: An Observational, Retrospective Study.
Antibiotics (Basel)
July 2023
Assistance Publique Hôpitaux de Marseille, Department of Anesthesiology and Intensive Care, Hôpital Nord, Aix-Marseille University, 13015 Marseille, France.
Background: Procalcitonin (PCT) protocols to guide antibiotic treatment for ventilator-associated pneumonia (VAP) in the intensive care unit aim at reducing antibiotic exposure. Our study goal was to measure compliance with a PCT protocol for VAP and to determine the associated variables.
Methods: From 2017 to 2021, we conducted a retrospective, monocentric study including patients treated for VAP.
Impact of a Procalcitonin-Based Protocol on Antibiotic Exposure and Costs in Critically Ill Patients.
Crit Care Explor
November 2021
Parkinson School of Health Sciences and Public Health, Marcella Niehoff School of Nursing, Loyola University Chicago, Chicago, IL.
Unlabelled: To examine the impact before and after adoption of a procalcitonin-based protocol to guide sepsis management has on antibiotic use, care costs, and outcomes of critically ill patients.
Design: Before-after study.
Setting: ICU of an academic tertiary care center.
Serum Procalcitonin as a Biomarker to Determine the Duration of Antibiotic Therapy in Adult Patients with Sepsis and Septic Shock in Intensive Care Units: A Prospective Study.
Indian J Crit Care Med
May 2021
Department of Anaesthesia and Intensive Care, Safdarjung Hospital and Vardhman Mahavir Medical College, New Delhi, India.
Background: Procalcitonin, a biomarker to adjudge the duration of antibiotic therapy in patients with sepsis.
Materials And Methods: A prospective, randomized, controlled, interventional, single-center study was conducted in a mixed adult intensive care unit (ICU). In a nonblinded study, 90 adult patients admitted to the ICU with sepsis and septic shock were randomized into group P (group procalcitonin) and group C (group control).
Decreased antibiotic exposure using a procalcitonin protocol for respiratory infections and sepsis in US community hospitals (ProCommunity).
Curr Med Res Opin
May 2021
Medical University Department, Kantonsspital Aarau and faculty at the University of Basel, Basel, Switzerland.
Article Synopsis
- The study investigates the effectiveness of a procalcitonin-based antibiotic stewardship program in community hospitals to reduce inappropriate antibiotic use, addressing the global concern of antimicrobial resistance.
- Conducted as a matched cohort study, the research compared patients from hospitals implementing the procalcitonin protocol with those from hospitals without it, focusing on various demographic and clinical factors.
- Results indicated that patients in procalcitonin cohort hospitals received 1.47 fewer days of antibiotic therapy, though there was a noted increase in acute kidney injury, but no significant differences in length of stay or other adverse outcomes.
Assessment of the impact of a new sequential approach to antimicrobial use in young febrile children in the emergency department (DIAFEVERCHILD): a French prospective multicentric controlled, open, cluster-randomised, parallel-group study protocol.
BMJ Open
August 2020
Paediatrics Emergency Department, CHU Nantes, Nantes, France.
Introduction: Fever is one of the most common reasons for consultation in the paediatric emergency department (ED). Because of fear of bacterial infection in parents and caregivers, clinicians often overprescribe laboratory tests and empirical antibiotic treatment. The aims of this study are to demonstrate that using a procalcitonin (PCT) rapid test-based prediction rule (1) would not be inferior to usual practice in terms of morbidity and mortality (non-inferiority objective) and (2) would result in a significant reduction in antibiotic use (superiority objective).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!